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Abstract
Introduction: Recent evidence suggests that bone marrow lesions (BMLs) play a pivotal role in knee osteoarthritis
(OA). The aims of this study were to determine: 1) whether baseline BML presence and/or severity predict site-
specific cartilage defect progression and cartilage volume loss; and 2) whether baseline cartilage defects predict
site-specific BML progression.
Methods: A total of 405 subjects (mean age 63 years, range 52 to 79) were measured at baseline and
approximately 2.7 years later. Magnetic resonance imaging (MRI) of the right knee was performed to measure knee
cartilage volume, cartilage defects (0 to 4), and BMLs (0 to 3) at the medial tibial (MT), medial femoral (MF), lateral
tibial (LT), and lateral femoral (LF) sites. Logistic regression and generalized estimating equations were used to
examine the relationship between BMLs and cartilage defects and cartilage volume loss.
Results: At all four sites, baseline BML presence predicted defect progression (odds ratio (OR) 2.4 to 6.4, all P <
0.05), and cartilage volume loss (-0.9 to -2.9% difference per annum, all P < 0.05) at the same site. In multivariable
analysis, there was a significant relationship between BML severity and defect progression at all four sites (OR 1.8
to 3.2, all P < 0.05) and BML severity and cartilage volume loss at the MF, LT, and LF sites (b -22.1 to -42.0, all P <
0.05). Additionally, baseline defect severity predicted BML progression at the MT and LF sites (OR 3.3 to 3.7, all P <
0.01). Lastly, there was a greater increase in cartilage volume loss at the MT and LT sites when both larger defects
and BMLs were present at baseline (all P < 0.05).
Conclusions: Baseline BMLs predicted site-specific defect progression and cartilage volume loss in a dose-response
manner suggesting BMLs may have a local effect on cartilage homeostasis. Baseline defects predicted site-specific
BML progression, which may represent increased bone loading adjacent to defects. These results suggest BMLs
and defects are interconnected and play key roles in knee cartilage volume loss; thus, both should be considered
targets for intervention.
Introduction
Bone marrow lesions (BMLs), detected by magnetic
resonance imaging (MRI), have been recognized as an
important feature in knee osteoarthritis (OA) [1,2]. A
number of studies have linked BMLs with knee pain
[1,3-5] although other studies have failed to demonstrate
such a relationship [6-8]. Baseline BMLs and increases
in BML size have been shown to predict cartilage defect
progression [9-12] and cartilage loss [9,10,13-18]. How-
ever, most of these studies have used a compartment-
level approach by combining tibial and femoral sites
[9,10,13-15] and/or medial and lateral tibiofemoral com-
partments [9,10]. The relationship between BMLs and
changes in site-specific cartilage has only recently been
examined [16-18]. Kothari et al. found that the presence
of BMLs at baseline was associated with cartilage loss in
the same subregion at two years [18]. In another study,
Roemer et al. examined BML changes with changes in
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any medium, provided the original work is properly cited.cartilage over time [17]. They reported that the absence
of BMLs at baseline and follow-up was associated with a
decreased risk of adjacent cartilage loss, while new or
progressive BMLs displayed a high risk of adjacent carti-
lage loss [17]. Cartilage scores in both of these studies
were assessed using the Whole-Organ Magnetic Reso-
nance Imaging Score (WORMS) method, which semi-
quantitatively scores cartilage integrity by using one
scale for both cartilage defects and cartilage loss. Alter-
natively, Raynauld et al. examined the subregional rela-
tionship between BMLs with a quantitative measure of
cartilage volume loss and found that an increase in bone
oedema was associated with cartilage volume loss in the
same subregions of the medial but not in the lateral
compartment [16]. Therefore, there is increasing evi-
dence to demonstrate that BMLs predict site-specific
cartilage changes; however, it remains unclear whether
BMLs at one site predict cartilage changes in another.
There is an ongoing debate about the role BMLs play
in the development of cartilage damage and loss. It
remains unclear whether BMLs precede, accompany, or
follow cartilage damage and volume loss in OA [18].
Many studies have shown that baseline BMLs predict
subsequent cartilage damage and/or loss [9-11,13-15,18];
however, to the best of our knowledge, there have been
no studies examining whether baseline cartilage defects
predict BML progression.
Therefore, the aims of this population-based longitudi-
nal study were to examine: 1) the relationship between
baseline BMLs and site-specific changes in cartilage
(defects and/or volume changes); 2) whether baseline
BMLs at one site predict cartilage changes (defects and/
or volume changes) in another; and 3) whether baseline
cartilage defects predict site-specific BML progression.
Materials and methods
Subjects
This study was conducted as part of the Tasmanian
Older Adult Cohort (TASOAC) study, an ongoing pro-
spective, population-based study that was initiated in
2002 and was aimed at identifying the environmental,
genetic, and biochemical factors associated with the
development and progression of OA at multiple sites
( h a n d ,k n e e ,h i p ,a n ds p i n e ) .S u b j e c t sb e t w e e nt h ea g e s
of 50 and 80 years were randomly selected from the
electoral roll in Southern Tasmania (population
229,000), with an equal number of men and women.
The overall response rate w a s5 7 % .S u b j e c t sw h ow e r e
institutionalized were excluded from the study. All
research conducted within this manuscript is in compli-
ance with the Helsinki Declaration and was approved by
the Southern Tasmanian Health and Medical Human
Research Ethics Committee. All subjects gave informed
written consent.
The current study consists of a sample of 405 partici-
pants who had MRI measures at baseline and follow-up.
The range of follow-up was 2.0 to 4.7 years (mean:
approximately 2.7 years). The majority of participants
(90%) were followed up between 2.2 to 3.2 years.
Anthropometrics
Weight was measured to the nearest 0.1 kg (with shoes,
socks, and bulky clothing removed) using a single pair
of electronic scales (Seca Delta Model 707, Bradford,
MA, USA). Height was measured to the nearest 0.1 cm
(with shoes and socks removed) using a stadiometer.
Body mass index (BMI) was calculated (kg/m
2).
Magnetic Resonance Imaging
An MRI of the right knee was acquired with a 1.5T
whole-body magnetic resonance unit (Picker, Cleveland,
OH, USA) using a commercial transmit-receive extre-
mity coil. Image sequence included the following: (1) a
T1-weighted fat saturation three-dimensional (3-D) gra-
dient recall acquisition in the steady state, flip angle 30°,
repetition time 31 ms, echo time 6.71 ms, field of view
16 cm, 60 partitions, 512 × 512-pixel matrix, acquisition
time 5 minutes 58 seconds, one acquisition; sagittal
images were obtained at a partition thickness of 1.5 mm
without between-slice gap; (2) a T2-weighted fat satura-
tion 3-D fast spin echo, flip angle 90°, repetition time
3,067 ms, echo time 112 ms, field of view 16 cm, 15
partitions, 228 × 256-pixel matrix; sagittal images were
obtained at a partition thickness of 4 mm with a
between-slices gap of 0.5 to 1.0 mm.
Cartilage morphology evaluation
Knee tibial cartilage volume was assessed by a trained
observer on T1-weighted MR images at baseline and fol-
low-up by means of image processing on an indepen-
dent workstation using Osiris software (University of
Geneva, Geneva, Switzerland) as previously described
[19,20]. The volumes of individual cartilage plates (med-
ial tibia and lateral tibia) were isolated from the total
volume by manually drawing disarticulation contours
around the cartilage boundaries on a section by section
basis. These data were then re-sampled by means of
bilinear and cubic interpolation (area of 312 × 312 mm
and 1.5 mm thickness, continuous sections) for the final
3-D rendering. The coefficient of variation (CV) was
2.1% for the medial tibia and 2.2% for the lateral tibia
[19]. Knee femoral cartilage volume was determined by
means of image processing on an independent worksta-
tion using Cartiscope™ (ArthroVision Inc., Montreal,
QC, Canada), as previously described [21-23]. The
segmentation of the cartilage-synovial interfaces was
carried out with the semi-automatic method under
reader supervision and with corrections when needed.
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dized view of 3D cartilage geometry as the sum of ele-
mentary volumes. The CV was approximately 2% [21].
The cartilage volume assessment was done for the med-
ial and lateral condyles delineated by the Blumensaat’s
line [22]. Absolute change in cartilage volume was cal-
culated as: follow-up cartilage volume - baseline carti-
lage volume. Rate of change in cartilage volume was
calculated as: percentage change per annum (pa) = 100*
((absolute change/baseline cartilage volume)/time
between two scans in years).
Cartilage defects were assessed by a trained observer
at baseline and follow-up on T1-weighted MR images
(score range, 0 to 4) at the tibial and femoral sites,
medially and laterally, as previously described [24] as
follows: grade 0 = normal cartilage; grade 1 = focal blis-
tering and intracartilaginous low-signal intensity area
with an intact surface and base; grade 2 = irregularities
on the surface or base and loss of thickness <50%; grade
3 = deep ulceration with loss of thickness >50%; and
grade 4 = full-thickness chondral wear with exposure of
subchondral bone. A cartilage defect also had to be pre-
sent on at least two consecutive slices. The cartilage was
considered to be normal if the band of intermediate sig-
nal intensity had a uniform thickness. If more than one
defect was present on the same site the highest score
was used. Intraobserver repeatability was assessed in 50
subjects with at least one week between the two mea-
surements with intraclass correlation coefficients (ICC)
of 0.93, 0.92, 0.95, and 0.80 at the medial tibia, medial
femur, lateral tibia, and lateral femur, respectively. Carti-
lage defect progression was defined as an increase of
one or more on the 0- to 4-point scale. Those whose
scores remained the same or decreased by one or more
were defined as stable or decreasing.
Subchondral BML evaluation
Subchondral BMLs were assessed by a trained observer
at baseline and followed-up on T2-weighted MR images
and defined as areas of increased signal adjacent to the
subcortical bone at the medial tibial, medial femoral, lat-
eral tibial, and lateral femoral sites. Each BML was
scored on the basis of lesion size (for example, a lesion
was scored as grade 1 if it was only present on one
slice, grade 2 if present on two consecutive slices, or
grade 3 if present on three or more consecutive slices).
The BML with the highest score was used if more than
one lesion was present at the same site. Intraobserver
repeatability was assessed in 50 subjects with at least a
one-week interval between the two readings with ICCs
of 0.94, 1.00, 0.89 and 0.96 at the medial tibia, medial
femur, lateral tibia, and lateral femur, respectively. BML
progression was defined as an increase of one or more
on the 0- to 3-point scale. Those whose scores remained
the same or decreased by one or more were defined as
stable or decreasing.
In an extended observation, BMLs were also scored
using a modified version of WORMS by a separate
research group, in order to compare the two scoring
systems. Briefly, BMLs were assessed on T1-weighted
MR images and the joint was divided into its anatomical
regions (medial and lateral condyle, medial and lateral
tibial plateau, and patella), which were further subdi-
vided into anterior, central, and posterior for the femur,
and medial and lateral for the patella and the tibial pla-
teaus. Subchondral bone marrow abnormalities were
then assessed comparing the surface of the lesion with
the surface of the subregion in the corresponding image.
If the lesion was depicted in multiple slides, the one
with the largest extent was chosen. When the lesion is
oriented along the latero-medial direction, a recon-
structed axial image is used for the evaluation. A scale
from 0 to 3 was used, where 0 = absence, 1 = < 25%,
2 = 25% to 50%, and 3 = > 50% of this ratio. The central
and posterior femoral subregions and the tibial plateau
formed the medial and lateral compartments. The med-
ial and lateral anterior femoral subregions and the two
patellar subregions formed the femoropatellar compart-
ment. The inter-reader reliability of this BML scoring
system has previously been shown to be excellent [16].
Meniscal damage evaluation
Meniscal damage evaluation at baseline was performed
by a trained observer as previously described [23]. In
brief, the proportion of the menisci affected by the tear
or extrusion was separately scored on the medial and
lateral edges of the tibiofemoral joint space using a
semi-quantitative scale. For tears the following scale
applied: 0 = no damage, 1 = one of three areas involved
(anterior, middle, posterior horns), 2 = two of three
involved, 3 = all three areas involved. The extent of
meniscal extrusion, not including the osteophytes, was
evaluated for the anterior, middle, and posterior horns
of the menisci in which 0 = no extrusion, 1 = partial
extrusion and 2 = complete extrusion with no contact
with the joint space (severe).
Cartilage volume measurements, cartilage defects,
BMLs, and meniscal damage scoring were all done inde-
pendently of one another.
Statistical analysis
Site-specific associations were defined as the associa-
tions within the same site (example, the association
between medial tibial BMLs and medial tibial defect
increases). Compartment-specific associations were
defined as the associations within the same compart-
ment (for example, the association between medial tibial
BMLs and medial femoral defect increases).
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ferences in means and proportions where appropriate.
Due to a lack of variation in baseline cartilage defect
score in this cohort, cartilage defects were dichotomized
for some analyses. Defect scores of 0 to 1 were coded 0
and of 2 to 4 were coded 1.
Logistic regression modeling was used to examine the
site and compartment-specific associations between
baseline BMLs with increases in cartilage defects
(increase versus no increase) and baseline defects with
increases in BMLs (increase versus no increase), after
adjustment for age, sex, BMI, and defects if BMLs and
BMLs if defects. As there is increasing evidence to sug-
gest that meniscal damage plays an important role in
disease progression, models were further adjusted for
meniscal damage. Meniscal damage has been shown to
predict cartilage loss [15,23] and BML development
[25,26]. Therefore, it is believed that meniscal pathology,
cartilage damage, and BMLs are all related, although the
time sequence of these pathological events is still
unclear. By further adjusting for meniscal damage we
were able to assess whether the associations between
BMLs and cartilage defects were independent of menis-
cal pathology. Due to the uncertainty of the chronologi-
cal order of these features, we have chosen to display
both the unadjusted and adjusted results. Standard diag-
nostic checks of model adequacy and unusual observa-
tions were performed. Hosmer-Lemeshow tests were
performed to assess goodness-of-fit.
Generalized estimating equations (GEE) were used to
examine the site and compartment-specific associations
between baseline BMLs and cartilage defects with
change in absolute cartilage volume after adjustment for
age, sex, BMI, baseline site-specific cartilage volume,
and defects if BMLs and BMLs if defects. Models were
then further adjusted for meniscal damage to assess the
independent effects of BMLs and cartilage defects on
cartilage volume loss. The interaction between baseline
BMLs and baseline defects on cartilage volume loss was
also examined.
A P-value less than 0.05 (two-tailed) was considered
statistically significant. All statistical analyses were per-
formed on Intercooled Stata 10.0 for windows (Stata-
Corp, College Station, TX, USA).
Results
Subjects
A total of 1,100 subjects (51% female) aged between 51
and 81 (mean: 63 years) participated in the TASOAC
study. The current study consists of a sample of 405
participants who had MRI measures at baseline and fol-
low-up. MRI scans were discontinued after this sample
due to decommissioning of the MRI scanner. There
were no significant baseline differences in demographics,
cartilage defects, BMLs, and cartilage volume between
the rest of the cohort and the subjects included in the
current study.
The characteristics of the study sample by presence or
absence of baseline BMLs at any site are presented in
Table 1. At all four sites, in unadjusted analysis, subjects
who had a BML at baseline had a higher prevalence of
baseline cartilage defects, lost more cartilage volume
from baseline to follow-up, and a higher proportion of
them increased in cartilage defects from baseline to fol-
low-up, compared with those subjects who did not have
a BML at baseline. There was limited variation in base-
line cartilage defect scores. No participants scored zero
at the medial or lateral tibial sites. The majority of parti-
cipants scored 1 and smaller numbers of participants
scored ≥2 at all four sites.
BMLs and cartilage defects
Site-specific associations
Figure 1 describes the site-specific univariate relation-
ship between (a) baseline BMLs and cartilage defect
increases and (b) baseline cartilage defects and BML
increases. There were a higher proportion of partici-
pants whose cartilage defects increased in those with a
BML at baseline versus those without a BML at baseline
(a). There were also a higher proportion of participants
whose BMLs increased in those with baseline defect
grades 2 to 4 versus those with defect grades 0 to 1 (b).
Table 2 describes the multivariable relationship
between baseline BML severity and cartilage defect
increases and baseline cartilage defect severity and BML
increases. BMLs predicted site-specific cartilage defect
increases in a dose-response fashion at each site, even
after further adjustment for meniscal damage. For exam-
ple, at the medial tibial site, the odds of a cartilage defect
increasing opposed to not increasing was 1.8 times more
per grade increase in baseline BML score. Cartilage
defect severity predicted site-specific increases in BMLs
in a dose-response manner also at each site; however,
after further adjustment for meniscal damage this only
persisted at the medial tibial and lateral femoral sites.
Compartment-specific associations
Medial femoral BMLs predicted medial tibial cartilage
defect increases (OR 1.7, 95% CI 1.1 to 2.7), and this
persisted after further adjustment for medial tibial BMLs
and meniscal damage (OR 1.9, 95% CI 1.2 to 3.0). BMLs
did not significantly predict compartment-specific defect
increases at any other site.
Lateral tibial defects predicted lateral femoral BML
increases (OR 2.3, 95% CI 1.5 to 3.7), and this persisted
after further adjustment for lateral femoral defects and
meniscal damage (OR 2.3, 95% CI 1.1 to 4.7). Defects
did not significantly predict compartment-specific BML
increases at any other site.
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Site-specific associations
Figure 2 describes the univariate relationship between
(a) baseline BMLs and (b) baseline cartilage defects with
cartilage volume loss at each site. Cartilage volume loss
was higher in those participants with a baseline BML
(a). Those participants with a baseline cartilage defect
score ≥2 lost significantly more cartilage at the medial
and lateral tibial sites (b).
Table 3 describes the multivariable relationship
between baseline BML and cartilage defect severity with
change in cartilage volume. BMLs predicted site-specific
cartilage volume loss at all four sites in a dose-response
fashion. After further adjustment for meniscal damage
this persisted at the medial femoral, lateral tibial, and
lateral femoral sites. Cartilage defects predicted cartilage
volume loss at the medial tibial site only; however, this
did not persist after adjustment for meniscal damage. At
the medial femoral site cartilage defects trended towards
predicting cartilage volume loss (P = 0.056).
Figure 3 shows the interaction between baseline BMLs
and cartilage defects on tibial cartilage volume loss.
There was a higher rate of cartilage volume loss at both
medial and lateral tibial sites when larger defects (grades
2 to 4) and BMLs (grades 2 to 3) were both present at
the same site. There was no interaction between base-
line BMLs and cartilage defects on femoral cartilage
volume (data not shown).
Compartment-specific associations
Although BMLs predicted site-specific cartilage volume
loss, they did not predict compartment-specific cartilage
volume loss at any site (data not shown). For example,
medial femoral BMLs did not predict medial tibial carti-
lage volume loss.
Additional analysis
The results above were corroborated when BMLs were
scored using the modified version of WORMS. Using
the original scoring system BMLs predicted site-specific
defect increases at all four sites (Table 2); whereas,
using the WORMS system BMLs predicted site-specific
defect increases at the medial femoral, lateral tibial, and
lateral femoral sites (OR 2.9 to 13.7, all P < 0.05). Using
the WORMS system BMLs predicted site-specific carti-
lage volume loss at the medial femoral, and lateral tibial
sites (b -50.1 to -122.1, all P < 0.05); whereas, using the
original scoring system BMLs also predicted cartilage
volume loss at the lateral femoral site (Table 3).
Discussion
This longitudinal study sheds light on the relationships
between BMLs, cartilage defects, and cartilage volume
loss. Baseline BMLs predicted site-specific cartilage
defect progression and cartilage volume loss in a dose-
response manner. To the best of our knowledge, this is
the first study to show baseline cartilage defects pre-
dicted site-specific BML progression. Furthermore, there
was an interaction between BMLs and cartilage defects
on cartilage volume loss, with a much greater rate of
tibial cartilage loss when both larger defects and BMLs
were present at baseline.
S t u d i e sh a v eo n l yr e c e n t l yb e g u nt oe x a m i n et h es i t e -
specific relationship between BMLs and cartilage
changes [16-18]. We have demonstrated a site-specific
Table 1 Characteristics of participants according to presence or absence of BMLs at baseline at each site*
Medial tibial Medial femoral Lateral tibial Lateral femoral
BML
absent
BML
present
BML
absent
BML
present
BML
absent
BML
present
BML
absent
BML
present
(n = 352) (n = 53) (n = 358) (n = 47) (n = 379) (n = 26) (n = 356) (n = 49)
Age (year) 63.2 (7.2) 63.5 (7.2) 63.3 (7.3) 62.7 (6.3) 63.1 (7.3) 65.0 (6.4) 63.3 (7.2) 63.0 (7.6)
Male sex (%) 49 53 49 57 50 46 47 65†
BMI (kg/m
2) 27.6 (4.4) 28.0 (4.8) 27.5 (4.5) 28.5 (4.0) 27.7 (4.5) 26.6 (2.7) 27.7 (4.5) 27.2 (4.1)
Cartilage defects present baseline
#
(%)
72 8 ‡ 15 43‡ 15 38‡ 53 1 ‡
Cartilage defect increase (%) 13 25† 23 44‡ 14 52‡ 17 41‡
Cartilage volume baseline (mL) 2,332 (580) 2,352 (563) 3,949
(1,135)
4,024 (1,089) 2,763 (681) 2,687 (807) 4,327
(1,194)
4,351 (876)
Cartilage volume loss per annum
(%)
-2.3 (5.3) -4.4 (5.1)† -1.1 (2.1) -2.2 (2.9)‡ -1.8 (4.0) -4.7 (6.2) ‡ -0.8 (2.0) -1.7 (1.9)†
BML increase (%) 11 17 51 5 † 11 12 12 27‡
*Mean (standard deviation) except for percentages. Bold denotes a statistically significant result. P-values determined by t-test or chi-square test (where
appropriate).
† P < 0.05.
‡ P < 0.01.
#Defined as grade 2 or higher.
BMI, body mass index; BMLs, bone marrow lesions; mL, millilitre.
Dore et al. Arthritis Research & Therapy 2010, 12:R222
http://arthritis-research.com/content/12/6/R222
Page 5 of 10relationship between BMLs and both cartilage defect
progression and a quantitative measure of cartilage
volume loss. We found that BMLs predicted cartilage
defect progression and cartilage volume loss at all four
sites (medial tibial, medial femoral, lateral tibial, and lat-
eral femoral). After further adjustment for meniscal
extrusions and tears, BMLs continued to predict carti-
lage defect progression at all four sites and cartilage
volume loss at the medial femoral, lateral tibial, and lat-
eral femoral sites, demonstrating the associations pre-
sented are independent of meniscal damage. Importantly
our results demonstrate a dose-response relationship
exists between BMLs and site-specific cartilage damage
and volume loss. For every unit increase in BML size,
the odds of a cartilage defect progressing increased and
more cartilage volume was lost over time. This is very
similar to a recent study by Tanamas et al. which
showed that the severity of BMLs was positively asso-
ciated with the risk of knee joint replacement in subjects
with well established OA [27]. Although our study
included those with and without OA, it suggests that
the size of the BML is important at different stages.
However, we are unaware of any study which shows
that BML size increases with stage of OA.
T h i ss t u d yi su n i q u ei nt h a ti ta l s oe x p l o r e dw h e t h e r
BMLs at one site predicted cartilage damage or volume
loss at another site. We observed only one compartmen-
tal association (medial femoral BMLs predicted medial
tibial cartilage defect increases). The site-specific nature
of most associations suggests BMLs may be having an
effect on the cartilage directly adjacent to the BML.
BMLs may precede cartilage damage by altering
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more, BMLs are made of a mix of cell infiltrates
[28,29] and possible cross-talk between subchondral
bone and cartilage [30] could induce catabolism of the
c a r t i l a g e .H o w e v e r ,i ti sa l s op o s s i b l et h a tB M L sm a y
be a secondary phenomenon as a result of cartilage
damage. Indeed, this is the first study to demonstrate
that baseline cartilage defects predicted site-specific
BML progression. After further adjustment for menis-
cal damage this relationship was seen at the medial
tibial and lateral femoral sites. Again we observed only
one compartment association (lateral tibial defects pre-
dicted lateral femoral BML increases). Cartilage defects
may exert an effect on the underlying bone by
increased load transmission to the bone, resulting in
BMLs. Alternatively, BMLs and cartilage defects may
not necessarily drive one another, although it is possi-
ble. They may co-occur in the pathway towards
increased disease. Therefore, it remains unclear
whether BMLs precede, accompany, or follow cartilage
damage and volume loss in OA [18].
Previous studies have shown that cartilage defects pre-
dict cartilage loss [31-33]. In this study, baseline carti-
lage defects predicted cartilage volume loss at the
medial tibial site only; however, this did not persist after
adjustment for meniscal damage. There was a trend
towards cartilage defects predicting cartilage volume
loss at the medial femoral site, independent of site-spe-
cific BMLs and meniscal damage. Baseline BMLs pre-
dicted cartilage volume loss at three of the four sites,
independent of site-specific defects and meniscal
damage. This demonstrates that BMLs were better than
cartilage defects at predicting cartilage volume loss.
Additionally, there was an interaction between baseline
cartilage defects and BMLs on tibial cartilage volume
loss at the medial and lateral sites, with a much greater
rate of tibial cartilage volume loss when both larger
defects and BMLs were present at the same site. This
supports a previous study, which used finite element
modeling to examine the effect of osteochondral defects
on the knee joint [34]. They found that cartilage altera-
tions were further exacerbated when bone damage was
combined with base cartilage split and absence of verti-
cal collagen fibrils [34].
Cartilage volume, cartilage defects, BMLs, and menis-
cal damage were all measured independently. This is a
strength of the study. However, this study has potential
limitations as well. First, follow-up MRI scans were only
available on a subsample of the full TASOAC study.
However, there were no significant differences between
the subjects included in the current study and those in
the rest of the cohort in regards to demographics, base-
line cartilage defects, BMLs, and cartilage volume. Sec-
ond, we used a study design with two time points to
Table 3 Baseline BMLs (0 to 3) and baseline cartilage
defects (0 to 4) predicting absolute changes in cartilage
volume
Multivariable b (95%
CI)†
Multivariable b (95%
CI)‡
Medial tibial
BMLs -24.5 (-47.0, -2.0)* -14.4 (-40.9, +12.1)
Cartilage
defects
-33.7 (-60.3, -7.1)* -5.0 (-43.6, +33.7)
Medial femoral
BMLs -42.0 (-63.6, -20.5)** -42.0 (-63.7, -20.4)**
Cartilage
defects
-17.2 (-34.7, +0.4) -17.2 (-34.8, +0.4)#
Lateral tibial
BMLs -35.2 (-56.1, -14.4)** -35.5 (-58.5, -12.6)**
Cartilage
defects
-12.6 (-34.2, +9.0) -21.7 (-50.2, +6.8)
Lateral femoral
BMLs -22.1 (-39.5, -4.7)* -22.1 (-39.5, -4.7)*
Cartilage
defects
-12.3 (-29.7, +5.1) -12.3 (-29.7, +5.1)
Bold denotes a statistically significant result. *P < 0.05, **P < 0.01.
† Adjusted for age, sex, body mass index, baseline site-specific cartilage
volume and defects if BMLs and BMLs if defects.
‡ Further adjusted for meniscal extrusion and meniscal tear.
#P = 0.056
b, beta-coefficient; BMLs, bone marrow lesions; CI, confidence interval.
Table 2 Association between BMLs and cartilage defects
Multivariable OR
(95% CI)†
Multivariable OR
(95% CI)‡
BMLs predicting defect
increases
Medial tibial BMLs 1.8 (1.2, 2.7)** 1.8 (1.1, 2.9)*
Medial femoral
BMLs
2.3 (1.5, 3.5)** 2.2 (1.4, 3.5)**
Lateral tibial BMLs 2.8 (1.8, 4.5)** 3.2 (1.9, 5.4)**
Lateral femoral
BMLs
3.3 (2.1, 5.0)** 3.0 (1.9, 4.8)**
Defects predicting BML
increases
Medial tibial
defects
3.7 (2.1, 6.5)** 3.3 (1.6, 6.8)**
Medial femoral
defects
2.2 (1.3, 3.8)** 2.0 (1.0, 4.1)
Lateral tibial
defects
2.5 (1.5, 4.2)** 1.6 (0.8, 3.4)
Lateral femoral
defects
2.6 (1.6, 4.2)** 3.7 (1.9, 7.3)**
Baseline BMLs (0 to 3) and site-specific increases in cartilage defects at the
same site and baseline cartilage defects (0 to 4) and site-specific increases in
BMLs at the same site.
Bold denotes a statistically significant result. *P < 0.05, **P < 0.01.
† Adjusted for age, sex, body mass index and baseline site-specific defects if
BMLs and site-specific BMLs if defects. All P-values < 0.01.
‡ Further adjusted for meniscal extrusion and meniscal tear.
BMLs, bone marrow lesions; CI, confidence interval; OR, odds ratio.
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gression and whether cartilage defects predicted BML
progression. A study with more than two time points
may give more insight into the causal pathways between
BMLs and cartilage damage. Third, knee malalignment
has been postulated as one factor explaining, at least in
part, the association between BMLs and cartilage loss in
OA [2,13]. However, in a previous study we found that
baseline malalignment was not associated with subse-
quent loss of cartilage volume or progression of chon-
dral defects [35]. Our current results suggest that
malalignment may not be the driving factor, considering
femoral BMLs did not predict tibial cartilage volume
loss. If the effect of BMLs on cartilage volume loss was
biomechanical, compartment-specific associations
between BMLs and cartilage volume loss would be
expected. However, because we did not have informa-
tion about malalignment we cannot conclusively say
whether or not malalignment plays a role in the associa-
tions we have seen. Fourth, cartilage defects were
assessed on T1-weighted gradient-recalled echo (GRE)
MR images and some research groups propose that GRE
type sequences are less suited to detect cartilage defects
[36]. We have recently published a letter to the editor of
Arthritis & Rheumatism to address this issue [37]. There
is evidence to demonstrate that GRE-type sequences are
accurate and reliable for detecting cartilage defects with
high sensitivity and specificity compared to arthroscopic
results [38-40]. While our measure of cartilage defects
may contain some measurement error and misclassifica-
t i o n ,i ti sl i k e l yt ob er a n d o ma n dw o u l dd i l u t et h e
effects we see, thus reducing our ability to detect signifi-
cant findings. Last, BMLs were read on T2-weighted
images using a scoring system which is widely-published
[3,41-43]; however, we have been made aware that scor-
ing BMLs based on how many slices they appear on
may bias towards flat but shallow lesions. For this rea-
son, we extended our observation and performed a sepa-
rate analysis in which BMLs were also scored by a
different research group using a modified version of the
WORMS method on T1-weighted images. Reading
BMLs on T1-weighted MRI sequences may result in a
more conservative analysis; however, d’Anjou et al.
recently published a letter to the editor of Osteoarthritis
and Cartilage to address whether non-cystic BMLs can
be accurately measured using GRE type sequences [44].
The authors presented evidence to demonstrate that
GRE type sequences are equally effective in detecting
the presence of BMLs compared with T2-weighted fast
spin echo sequences [44]. The results of the current
study using both scoring systems with the two sequence
t y p e sw e r eh i g h l yc o n s i s t e n tp r o v i d i n gr e a s s u r a n c et h a t
our findings are valid.
Conclusions
Baseline BMLs predicted site-specific defect progression
and cartilage volume loss in a dose-response manner,
which suggests BMLs may have a local effect on carti-
lage homeostasis. Baseline cartilage defects predicted
site-specific BML progression, which may represent
increased bone loading adjacent to defects. These results
suggest BMLs and cartilage defects are interconnected
and play key roles in knee cartilage volume loss; thus,
both should be considered targets for intervention.
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Figure 3 Interaction between baseline BMLs and baseline
cartilage defects on tibial cartilage volume loss (% per annum).
There was a significant interaction between (a) medial tibial BMLs
and medial tibial cartilage defects; and (b) lateral tibial BMLs and
lateral tibial cartilage defects, for site-specific cartilage volume loss.
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